Dr. Gulick is Chief of the Division of Infectious Diseases in the Department of Medicine and Professor of Medicine at Weill Medical College of Cornell University and Attending Physician at the New York-Presbyterian Hospital in New York City. His research area of interest is antiretroviral therapies for HIV infection. He also is active as a clinician specializing in HIV/AIDS and infectious diseases. He is board certified in Internal Medicine and Infectious Diseases.
Dr. Gulick is Chief of the Division of Infectious Diseases of the Department of Medicine and Professor of Medicine at Weill Medical College of Cornell University, and Attending Physician at the New York-Presbyterian Hospital in New York City. Prior to this, he was Director of the HIV Research Clinic at Bellevue Hospital in New York City and Medical Director of the Virology Research Clinic at Beth Israel Hospital in Boston. He has also taught at New York University School of Medicine and Harvard Medical School.
Dr. Gulick received his undergraduate education at Johns Hopkins University. In his early career, he worked as a Biologist in the Medicinal Chemistry Laboratory at the National Institutes of Health in Bethesda, MD. He went on to earn his MD degree at Columbia University College of Physicians and Surgeons and his Master of Public Health degree at Harvard University, focusing on clinical trial design. After completing his internship and residency in internal medicine at Columbia-Presbyterian Medical Center, Dr. Gulick held fellowships in infectious diseases at Beth Israel Hospital and Massachusetts General Hospital in Boston.
Dr. Gulick’s current research interests include designing, conducting and analyzing clinical trials to assess antiretroviral drugs with new mechanisms of action, refine antiretroviral therapy strategies, and test immune-based therapies. He currently serves as Principal Investigator of the Cornell Clinical Trials Unit and as Chair of the Optimization of Antiretroviral Therapy Committee of the AIDS Clinical Trials Group (ACTG), sponsored by the National Institutes of Health. He also serves as a Board Member of the International AIDS Society-USA and as a member of the Panel on Clinical Practices for the Treatment of HIV Infection of the U.S. Department of Health and Human Services. He previously served as Chairman of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA), and as Co-Chairman of the Forum for Collaborative HIV Research.
He is board certified in internal medicine and infectious diseases and a member of the New York Infectious Diseases Society, Infectious Diseases Society of America, the International AIDS Society, and the American Society of Clinical Investigation, among other organizations. He has presented at national and international meetings and published widely in the field of HIV/AIDS.
